C19 IVM News

On January 14, the NIH COVID-19 Treatment Panel allowed Ivermectin (IVM) for early treatment of COVID-19. Technically, it changed its position from negative to neutral. The opinion of the NIH COVID-19 Treatment Panel has no legal weight and almost no scientific value, but hospitals and many doctors were afraid to go against its recommendations.

Now doctors can prescribe IVM without fear.

Effectiveness of Ivermectin for COVID-19 has been shown in more than 50 studies. Some publications:

AAPS Applauds NIH Revised Stance on Ivermectin for COVID-19

‘This was a gift to us’: Ivermectin effective for COVID-19 prophylaxis, treatment

Not Using Ivermectin, One Year In, Is Unethical And Immoral (trialsitenews.com)

Frequently Asked Questions on Ivermectin

If you or your relatives feel symptoms consistent with COVID-19, ask your doctor for Ivermectin based treatment.


The treatment protocols are for doctors’ eyes only

EVMS, Critical Care for C19

A Guide to Ambulatory C19 Treatment from AAPS

A review of treatments by Eleftherios Gkioulekas